Literature DB >> 21105780

Cytolytic CD4(+) T cells in viral immunity.

Damien Z Soghoian1, Hendrik Streeck.   

Abstract

It is generally believed that the role of CD4(+) T cells is to coordinate the different arms of the adaptive immune system to shape an effective response against a pathogen and regulate nonessential or deleterious activities. However, a growing body of evidence suggests that effector CD4(+) T cells can directly display potent antiviral activity themselves. The presence of cytolytic CD4(+) T cells has been demonstrated in the immune response to numerous viral infections in both humans and in animal models and it is likely that they play a critical role in the control of viral replication in vivo. This article describes the current research on virus-specific cytolytic CD4(+) T cells, with a focus on HIV-1 infection and the implications that this immune response has for vaccine design.

Entities:  

Mesh:

Year:  2010        PMID: 21105780      PMCID: PMC3033049          DOI: 10.1586/erv.10.132

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  119 in total

1.  Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression.

Authors:  Z Fu; M J Cannon
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  TRAIL (Apo2 ligand) and TWEAK (Apo3 ligand) mediate CD4+ T cell killing of antigen-presenting macrophages.

Authors:  M J Kaplan; D Ray; R R Mo; R L Yung; B C Richardson
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

Review 3.  How are T(H)2-type immune responses initiated and amplified?

Authors:  William E Paul; Jinfang Zhu
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

4.  Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.

Authors:  Kathleen A Stuller; Stephanie S Cush; Emilio Flaño
Journal:  J Immunol       Date:  2010-03-05       Impact factor: 5.422

Review 5.  Differentiation of effector CD4 T cell populations (*).

Authors:  Jinfang Zhu; Hidehiro Yamane; William E Paul
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

6.  Foxp3+ T cells induce perforin-dependent dendritic cell death in tumor-draining lymph nodes.

Authors:  Alexandre Boissonnas; Alix Scholer-Dahirel; Virginie Simon-Blancal; Luigia Pace; Fabien Valet; Adrien Kissenpfennig; Tim Sparwasser; Bernard Malissen; Luc Fetler; Sebastian Amigorena
Journal:  Immunity       Date:  2010-02-04       Impact factor: 31.745

7.  The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3.

Authors:  Kazuyoshi Kohu; Hidetaka Ohmori; Won Fen Wong; Daisuke Onda; Takeshi Wakoh; Shunsuke Kon; Masakatsu Yamashita; Toshinori Nakayama; Masato Kubo; Masanobu Satake
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

8.  Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein.

Authors:  O Schwartz; V Maréchal; S Le Gall; F Lemonnier; J M Heard
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

9.  Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers.

Authors:  J Zhang; I Scordi; M J Smyth; M G Lichtenheld
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

10.  Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.

Authors:  B P Mahon; K Katrak; A Nomoto; A J Macadam; P D Minor; K H Mills
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more
  65 in total

1.  HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome.

Authors:  Srinika Ranasinghe; Michael Flanders; Sam Cutler; Damien Z Soghoian; Musie Ghebremichael; Isaiah Davis; Madelene Lindqvist; Florencia Pereyra; Bruce D Walker; David Heckerman; Hendrik Streeck
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.

Authors:  Yi Yang; Weilai Sun; Jingjing Guo; Guangyu Zhao; Shihui Sun; Hong Yu; Yan Guo; Jungfeng Li; Xia Jin; Lanying Du; Shibo Jiang; Zhihua Kou; Yusen Zhou
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.

Authors:  Susan Johnson; Michael Eller; Jeffrey E Teigler; Sebastien M Maloveste; Bruce T Schultz; Damien Z Soghoian; Richard Lu; Alexander F Oster; Agnès-Laurence Chenine; Galit Alter; Ulf Dittmer; Mary Marovich; Merlin L Robb; Nelson L Michael; Diane Bolton; Hendrik Streeck
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome.

Authors:  Damien Z Soghoian; Heiko Jessen; Michael Flanders; Kailan Sierra-Davidson; Sam Cutler; Thomas Pertel; Srinika Ranasinghe; Madelene Lindqvist; Isaiah Davis; Kimberly Lane; Jenna Rychert; Eric S Rosenberg; Alicja Piechocka-Trocha; Abraham L Brass; Jason M Brenchley; Bruce D Walker; Hendrik Streeck
Journal:  Sci Transl Med       Date:  2012-02-29       Impact factor: 17.956

5.  Vaccination Produces CD4 T Cells with a Novel CD154-CD40-Dependent Cytolytic Mechanism.

Authors:  Rhea N Coler; Thomas Hudson; Sean Hughes; Po-Wei D Huang; Elyse A Beebe; Mark T Orr
Journal:  J Immunol       Date:  2015-08-21       Impact factor: 5.422

6.  Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.

Authors:  Jeffrey E Teigler; Gennadiy Zelinskyy; Michael A Eller; Diane L Bolton; Mary Marovich; Alexander D Gordon; Aljawharah Alrubayyi; Galit Alter; Merlin L Robb; Jeffrey N Martin; Steven G Deeks; Nelson L Michael; Ulf Dittmer; Hendrik Streeck
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

7.  Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection.

Authors:  Shilpi Verma; Daniela Weiskopf; Ankan Gupta; Bryan McDonald; Bjoern Peters; Alessandro Sette; Chris A Benedict
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma.

Authors:  Katherine A Murphy; Jami R Erickson; Charles S Johnson; Charles E Seiler; Jessica Bedi; Peisheng Hu; G Elizabeth Pluhar; Alan L Epstein; John R Ohlfest
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

9.  Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease.

Authors:  Hamid Mattoo; Vinay S Mahajan; Takashi Maehara; Vikram Deshpande; Emanuel Della-Torre; Zachary S Wallace; Maria Kulikova; Jefte M Drijvers; Joe Daccache; Mollie N Carruthers; Flavia V Castelino; James R Stone; John H Stone; Shiv Pillai
Journal:  J Allergy Clin Immunol       Date:  2016-03-11       Impact factor: 10.793

10.  Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.

Authors:  Nicholas A Siciliano; Adam R Hersperger; Aimee M Lacuanan; Ren-Huan Xu; John Sidney; Alessandro Sette; Luis J Sigal; Laurence C Eisenlohr
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.